FROM OUR EXPERTS
This question has not been answered by one of our experts yet.
Sometimes, things do not go as we like and breast cancer returns in a different site from the breast - a metastatic site. It's what patients all fear with each little ache and pain, and what your oncologist looks for at each follow up visit. Less common these days is the patient who presents with metastatic disease at the outset - this can be seen with a very aggressive breast cancer, or with a patient who sometimes delays seeking treatment for a primary tumor which has time to develop overt metastases.
Sadly, metastatic breast cancer remains incurable and while some progress has been made we have a lot more room to go.
The identification of HER2 as a therapeutic target and the development of Herceptin - a targeted therapy against HER2 positive breast cancer - has probably been the greatest contribution to metastatic disease in the past ten years.
Metastatic breast cancer can recur in any organ, but most commonly returns in the bone, lung or liver. The "bone on...
Recent research shows that women with dense breasts are at increased risk of breast cancer. As with any group at higher risk, it’s recommended that these women pay special attention to their breasts – both by checking regularly for new lumps, and by receiving periodic cancer screening. Problem is, dense breasts are also very difficult to successfully screen; and a challenge when it comes to self-exams. Thus there’s a higher probability that women with dense breasts will undergo a biopsy, or multiple biopsies – most or all of which will be negative, resulting only in scars, pain, and stress. Could a combination of ultrasound and a newly revived technology, elastography, save these women from needless biopsies and their accompanying anxiety? A friend of mine, call her Jen, is a younger woman who’s lithe, fit, and athletic. She’s never sick, avoiding the flu and colds most of us experience as a matter of course. However, Jen has one health issue that dri...
Article last updated on March 31, 2014 Background Inflammatory breast cancer (IBC) is a relatively rare type of breast cancer that grows in the lymph vessels of the skin of the breast. Because it usually doesn’t form an easy-to-find lump and because it tends to spread rapidly, IBC is the most deadly form of breast cancer. Because the cancer is in the lymphatic system at the time of diagnosis, IBC is considered a Stage IIIB cancer unless it has already spread to other organs, which would make it a Stage IV cancer for those patients. The median age of IBC patients is about 57, compared to over 62 years old for other breast cancers, but much younger women often get IBC. Statistics for IBC vary, but in North America, IBC accounts for about 1% to 5% of all breast cancers. The IBC rate for women of African descent may be as high as 10%. For a long time, doctors considered IBC to be regular breast cancer cells that were more dangerous because they were in the lymph system. Recent research...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.